Health and social care services research  
Expert Position and Main Activity Institution
Prof. Henrique Barros Full Professor, Epidemiology, University of Porto Medical School, Porto.
President, Institute of Public Health, University of Porto, Porto, Portugal.
Main activity: teaching of medical students and graduate students in public health. Coordinator of the Master and PhD programs in Public Health, at the University of Porto. Research in perinatal health, violence and infectious diseases.
Medical School and Institute of Public Health, Univrsity of Porto
Dr. Enrique Bernal-Delgado (EU coordinator and spokesperson) Current position: Senior Health Services Researcher in the Health Services Research and Health Policy Unit at the Institute for Health Sciences in Aragon – IIS Aragon (Spain).
Main ongoing projects: (i) Variations in Medical Practice in Spanish National Health System ; (ii) ECHO project, Variations in Systems Performance in Europe ; (iii) Spanish Leading Institution – WHO´s European Observatory on Health Systems and Policies ; (iv) REDISECC – Spanish Network for Health Services Research in Chronic Care.
Other current merits:
(i) Chief Editor -Atlas of Variations in Medical Practice in the National Health System ; (ii) Associate Editor – BMC Health Services Research.
Institute for Health Sciences, IIS Aragon
Dr. Manuel Espinoza Manuel is Assistant Professor and Head of the Unit of Health Technology Assessment at the Centre for Clinical Research, Faculty of Medicine, Pontificia Universidad Católica de Chile. He is also Scientific Coordinator of the National Centre for Pharmacoeconomics.
His research is focused on the development of methods and applied research in economic evaluations of healthcare interventions as well as methods and processes for decision making about coverage of healthcare technologies.
Department of Public Health, Pontificia Universidad Católica de Chile ; National Centre for Pharmacoeconomics, Institute of Public Health of Chile
Dr. Malaquías López Cervantes Medical Doctor by the National Autonomous University of Mexico (UNAM), with a master and Ph.D in Epidemiology and Public Health by the University of Yale. His professional career includes teaching, government and research, areas where he was been recognized with awards and distinctions at the national and international level. He is a member of the National System of Researchers (SNI) at its top level III; of the National Medicine Academy and of the Mexican Academy of Sciences. Nowadays he is a professor and Coordinator of the Unit of Special Research Projects at the Faculty of Medicine at the National Autonomous University of Mexico (UNAM) where problems of epidemiology, public health and health systems are being addressed. National Autonomous University of Mexico
Dr. Antonio Pietroiusti Assistant Professor. Involved in research on health promotion in occupational setting and on the impact of nanotechnology on human health. Official partner in EU Fp7 large projects MARINA (Managing the risk of nanoparticles) and NanoReg (A common European approach to the regulatory testing of manufactured nanomaterials). Member of the management Committee of the COST action MODENA (Modelling the risk of nanoparticles). Author of about 100 peer-reviewed research articles. Università di Roma Tor Vergata
Prof. Karl Theodore (LAC coordinator) PhD. Professor of Economics in the Department of Economics. Leader of a multidisciplinary team at HEU, main contributor to a better understanding of the economic impact of HIV/AIDS in the Caribbean and a better estimation of the cost of responding to the epidemic. HEU, Centre for Health Economics, The University of the West Indies, St. Augustine
Expert Position and Main Activity Institution
Dr. Pablo Bonvehí Chairman of the Infectious Diseases Unit at Centro de Educación Médica e Investigaciones Clínicas (CEMIC) Buenos Aires, Argentina. Director of the Posgraduate University Career on Infectious Diseases at Instituto Universitario CEMIC Buenos Aires, Argentina. President of the National Advisory Committee on Immunizations. Ministry of Health. Argentina. CEMIC
Prof. Dr. Pedro Cahn I have been working in infectious diseases for the last 35 years. I am Chief of Infectious Diseases at Fernandez Hospital, Founder and President of Fundacion Huesped (the largest NGO in Argentina devoted to HIV/AIDS), as well as Past President of the International AIDS Society. I am Assistant Professor of Infectious Diseases at the Buenos University. I served as advisor for UNAIDS, WHO, PAHO, UNITAID, MSF, as well as a member of the ARV guidelines panel both for WHO and the IAS-USA. Fundación Huesped
Dr. Manuel Cuenca Estrella (EU coordinator and spokesperson) Director of the Spanish National Center for Microbiology and the Scientific Director of the Spanish Reference Laboratory of Medical Mycology where run a variety of research projects and scientific activities focused on fungal infections afflicting humans, early diagnosis of invasive fungal infections, standardization of antifungal susceptibility testing, resistance mechanisms, and taxonomy of fungal species. Spanish National Center for Microbiology
Dr. José Paulo Gagliardi Leite (LAC coordinator) Pharmacy (1979, UFRJ); Master-Biology of Parasites (1983, IOC-Fiocruz); Ph.D-Biochemistry (1988, Lille University, France); Postdoctoral (1994-1995, CDC). Senior Researcher, Head -Laboratory of Comparative and Environmental Virology (1991-2012), Professor of the Pos-Graduation Programs: Cellular-Molecular Biology and Biology of parasites, Associate Editor – Memorias do Instituto Oswaldo Cruz, IOC-Fiocruz. President – Brazilian Society for Virology (1997-1998); Advisor of PAHO: Rotavirus Surveillance Program and WHO – Rotavirus Technical Working Group (since 2009). Oswaldo Cruz Institute – Oswaldo Cruz Foundation (IOC-Fiocruz)
Dr. Fernando De la Hoz Restrepo General Director of the Colombian National Institute of Health. Coordination of research activities and surveillance on compulsory notifiable diseases for Colombia. Coordinator of research projects on assessment of effectiveness of rotavirus and hepatitis B vaccines in Colombia. Participation in prioritization activities for public health research in Colombia. Advisor of WHO for operational research on vaccines (member of the IVIR AC advisory committee). Instituto Nacional de Salud de Colombia
Dr. Stefano Vella I received my degree in Medicine from the University of Rome in 1977. I subsequently achieved specialty degrees in both Infectious Diseases (1982) and Internal Medicine (1987). After a postdoctoral experience at the University of Pennsylvania (1981-1982), I joined the medical staff at the Institute of Internal Medicine, University La Sapienza, Rome. In 1991, I was appointed Research Director of HIV/AIDS at the Istituto Superiore di Sanità (ISS), the Italian National Institute of Health. Since 2003, I chair the Department of Pharmacology and Therapeutic Research of the ISS. Istituto Superiore di Sanità – Italy
  Neurological diseases and stroke  
Expert Position and Main Activity Institution
Dr. Gabrielle Britton (LAC coordinator and spokesperson) My research is focused on the study of healthy and pathological aging. We employ basic (i.e. animal models and molecular genetics) and clinical approaches (i.e. cohort studies with aged individuals) to the study of the neurobiological processes underlying normal aging and aging-associated pathologies, with a particular emphasis on neurodegenerative diseases such as Alzheimer’s disease and mood disorders such as depression. Center for Neuroscience and Clinical Research Unit, INDICASAT AIP, Panamá
Prof. José Castillo Prof. Castillo is professor in neurology at the University of Santiago de Compostela. Likewise, he is the chief of Neurology Department of the University Clinical Hospital of Santiago de Compostela.
Porf. Castillo led (more than 10 years ago) the establishment of the Stroke Unit of the University Clinical Hospital of Santiago de Compostela (CHUS), the Neurosciences Area of the CHUS (2008), and the Clinical Neurosciences Research Laboratory (2005), leading those units since then. He is also the Director of the Department of Medicine of the Faculty of Medicine of the University of Santiago de Compostela (USC), and the director of the Health Research Institute of Santiago de Compostela (IDIS).
Prof. Castillo also led the creation of the Neurovascular Research Network of the Carlos III Institute (Spanish Ministry of Health), of which he is the national coordinator, and that counts with more than 100 associated neuroscientists.
With more than 450 publications (including 17 books, 67 book chapters, 386 original articles, 7 patents, and 5 references in the ESO -European Stroke Organization- Stroke Management Guidelines) Prof. Castillo is making a notable scientific contribution at international level (with an cumulative impact factor of >800 in the last 10 years, ca. 6500 citations, about 600 per year since 2005, and a h-index of 42).
His career has also been devoted to teach and inspire young professionals either as medical doctors or researchers (and usually both at the same time). Thus, he was the director of 3 monographic doctoral courses, teacher of 22 monographic doctoral courses, head teacher of 8 seminars of the doctorate program in medicine of the USC, tutor of 9 doctorate programs, director of 2 master courses, director of 40 undergraduate dissertations and 23 PhD theses.
Finally, Prof. Castillo was the PI of 27 granted projects (Spanish Ministries of Health and Science and Innovation, and Galician Government; around 8.2 million €; in total).
Health Research Institute (IDIS), Santiago de Compostela
Dr. Marcelo Kauffman Dr. Marcelo Kauffman is the Head of the Neurogenetics Clinic and Laboratory at the Hospital JM Ramos Mejia in Buenos Aires, Argentina. He obtained his MD, MSc and PhD degrees from the University of Buenos Aires and from the University Pablo de Olavide in Spain. He completed his Residency in Neurology at the Hospital JM Ramos Mejia in Buenos Aires. He is researcher at the Argentine’s National Science Council (CONICET) and Assistant Professor of Neurology at the School of Medicine from the University of Buenos Aires. His clinical and research interests include the diagnosis, management and treatment of Neurogenetic Disorders. He has received many clinical and scientific awards and authored more than 40 peer-review papers, mainly on the field of neurogenetic diseases. Consultorio y Laboratorio de Neurogenetica. Hospital JM Ramos Mejia. Buenos Aires. Argentina
Dr. Rita Raisman –Vozari (EU coordinator) Research Director, PhD Responsible of research projects concerning neuronal death, neuro-plasticity, protein aggregation and neuro-inflammation in Parkinson and Alzheimer
French coordinator of different international projects with Latin America countries like Argentina, Chili and Brazil for studies in neurodegenerative illness.
INSERM, UMR1127, CRICM, UPMC ; ICM, CNRS UMR 7225, Paris, France.
Prof. María Luisa Sacchetti Researcher. Expert in stroke and related sleep disturbances. Experienced in health economics, health care management, organization of emergency medical services. Teacher of the: Degree Course in Medicine; School of Specialization in Neurology; Vice President of the Degree Course in Rehabilitation dedicated to physiotherapists. Collaborates with the Regional Agency of Health and with the Italian Minister of Health for the development of organizational strategies for stroke management Università degli Studi di Roma “La Sapienza”
Dr. Rodrigo Salinas Assistant professor of clinical neurology at the Faculty of Medicine of the University of Chile. Consultant at the Ministry of Health of Chile. President of the Ethics Committee of the National Research Council (CONICYT) Universidad de Chile
  Chronic diseases  
Expert Position and Main Activity Institution
Dr. Carlos A. Aguilar Salinas (LAC coordinator and spokesperson) Deputy Head of the Department of Endocrinology and Metabolism of the Instituto Nacional de Ciencias Medicas y Nutricion, Mexico City. Specialist in internal medicine and endocrinology. His main research line is the epidemiology, pathophysiology and treatment of the dyslipidemias, diabetes and components of the metabolic syndrome. Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubiran, Mexico City
Dr. Mauricio Lima Barreto Dr. Mauricio Lima Barreto is Professor of epidemiology at the Federal University of Bahia and has served as a CNPq honorary senior researcher since 1998. In 2003, he was elected Fellow of the Brazilian Academy of Sciences, and in 2013 Fellow of the World Academy of Sciences (TWAS). From 2002 until 2008 he was Councilor for Latin America and Caribbean of the International Epidemiological Association. He has served as a member of the Scientific Technical Council in CAPES/Brazil, coordinated Public Health and Nutrition Advisor Committee at CNPq and he has participated in several advisory committees for the World Health Organization. He leads a research group focused on epidemiological aspects of infectious diseases, malnutrition and asthma, assessment of impact of population interventions and theoretical and methodological aspects of epidemiology. He coordinates CITECS, a multi-institutional programme devoted to science, technology and innovation in health. He has published over 330 papers in peer reviewed scientific journals. He has taught students at levels from undergraduate through doctorate. Dr. Barreto holds his medical degree and a Master´s in community health from the Federal University of Bahia, and a Ph.D. in Epidemiology from the University of London. Nation Council for Scientific and Technological Development (CNPq)
Prof. Dr. Luis Castaño Professor of Pediatrics (Pais Vasco University- UPV/EHU); Pediatrician – Pediatric Endocrinologist; Endocrinology and Diabetes Researcher of BioCruces; Scientific Director of CIBERDEM (Spanish Diabetes Research network); Research Vice-Director of Hospital Universitario Cruces- BioCruces Hospital Universitario Cruces ;
Universidad del Pais Vasco – UPV/EHU ;
Prof. Dr. Mathias Fasshauer (EU coordinator) Position: Deputy Director, Department of Endocrinology and Nephrology, University of Leipzig and Professor for Endocrinology of Obesity, IFB AdiposityDiseases, University of Leipzig
Main activity: (i) Pathogenesis, treatment, and prevention of obesity and its complications ; (ii) Adipokines and adipose tissue dysfunction in obesity and its complications ; (iii) Pathophysiology and treatment of lipodystrophy
University of Leipzig, Department of Endocrinology and Nephrology ; IFB AdiposityDiseases
Dr. Daniel Ferrante Position: Coordinator of National Cardiovascular Diseases Program, Ministry of Health.
Main activity: development and implementation of national clinical practice guidelines on cardiovascular disease in primary care and specialized care, coordination of health promotion activities, population based surveillance (National Risk Factor Surveys) and research in non-communicable diseases.
Formerly worked in WHO at Geneva in the Noncommunicable Diseases and Mental Health Cluster.
Ministry of Health, Argentina
Prof. Davide Lauro Professor of Endocrinology and Diabetology, Director of Clinical Division on Endocrinology, Diabetology and Metabolic Diseases, Director of the Endocrinology and Metabolic Diseases Residency Program at University of Rome Tor Vergata. Specific area of interest are type 2 diabetes and metabolic diseases: The research area are on the study of (i) insulin signaling through cell and molecular biology techniques ; (ii) insulin resistance in clinical trials. Department of System Medicine, University of Rome Tor Vergata, Italy.
  Prevention of diseases and Promotion of well-being  
Expert Position and Main Activity Institution
Dr. Marisa Buglioli Bonilla 8 years working in the design and implementation of the Health Reform team In the Ministry of Public Health (MSP) of Uruguay. Currently, in International Relations Area: (i) Tracking of the international and global health agenda ; (ii) Studying, analysising, and collaborating in the construction of national positions in the multilateral and regional level (MERCOSUR, UNASUR) ; (iii) Coordination with the Ministry of Education and Culture for the investigation in health topics, and with the WHO technicians. Ministry of Public Health (MSP) , International Relations Advisory ; Professor Director of the Department of Preventive and Social Medicine, Faculty of Medicine, Universidad de la República (UDELAR), Uruguay.
Dr. Antonio Giulio de Belvis (EU coordinator and spokesperson) Antonio Giulio de Belvis is Medical Doctor at the School of Medicine of the Catholic University “Sacro Cuore” in Rome, post-graduated in Hygiene and Preventive Medicine in 2000, MSc in Epidemiology and Biostatistics in 2004.
Assistant Professor at the Catholic University from 2003, he was the coordinator of Clinical Governance Unit (2003-2007), the Primary Care Unit (2008-2010) and from 2011 the Population Medicine Unit at the Department of Hygiene and Public Health, Catholic University, Rome.
From 2009 to 2012 he was Scientific Secretary of the National Observatory for the Health of the Italian Regions, National Leading Institution for the WHO European Observatory on Healthcare systems and policies.
Since August 2012 he is the Clinical Governor of the Teaching Hospital “Agostino Gemelli” in Rome.
Catholic University “Sacro Cuore” ; Policlinico Universitario “Agostino Gemelli”.
Dr. Valentin Fuster General Director of the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) in Madrid, Director of the Cardiovascular Institute and Physician-in-Chief at the Mount Sinai Medical Center in New York and Chairman of the SHE Foundation (Science for Health and Education).
His contributions in cardiovascular medicine have had an enormous impact in the improvement of treatment of patients with coronary illnesses. He has also significant worldwide recognized contributions to the promotion of global health and educational programs.
Centro Nacional de Investigaciones Cardiovasculares (CNIC) ; Mount Sinai Heart
Prof. Rainford Wilks Professor of epidemiology and director of the Epidemiology Research Unit in the TMRI, UWI since 1999. Consultant physician. Research focused on chronic non-communicable diseases, particularly the cardiovascular diseases in developing countries. Led national health surveys and cohort studies in Jamaica, the Caribbean and the African Diaspora. Teach medical students; masters in epidemiology, nutrition and public health; doctorates in epidemiology, nutrition and public health. Developed first masters and doctoral training programmes in epidemiology in CARICOM. Advisor to universities, governments and international organizations The University of the West Indies at Mona, Jamaica ; Tropical Medicine Research Institute (TMRI).
Dr. Miguel Rojas-Chaves (LAC coordinator) Professor and researcher of the Biotechnology Engineering career program at the Costa Rican Technology Institute (TEC). Currently coordinator of the Biotechnological Research Center (CIB), which has three main research areas: plant biotechnology, environmental biotechnology and biomedical applications. Research topic: production of autologous human keratinocytes and fibroblasts for treating skin pathologies. Tecnológico de Costa Rica
Expert Position and Main Activity Institution
Dr. Eduardo Cazap (LAC coordinator and spokesperson) Founder and first President of the Latin American & Caribbean Society of Medical Oncology (SLACOM); President of the International Union against Cancer (UICC-Geneva) 2010-2012. Member of the Executive Board of the National Cancer Institute of Argentina. Chairman of the Executive Committee of the Breast Health Global Initiative (BHGI), Seattle, Washington. President of the UICC World Cancer Congress ,Montreal, Canada, 2012.
Chairman of the International Clinical Trials Working Group (ICTWG)-American Society of Clinical Oncology (ASCO). He published over 170 papers.
Sociedad Latinoamericana y del Caribe de Oncología Médica (SLACOM)
Prof. John Ellershaw (EU coordinator) Professor of Palliative Medicine and Director of the Marie Curie Palliative Care Institute Liverpool, a research partnership between the University of Liverpool, the Royal Liverpool University Hospital and Marie Curie Cancer Care which aims to facilitate and support those who want to make a local, national or international difference to drive up quality for care of the dying. Marie Curie Palliative Care Institute Liverpool, University of Liverpool
Dr. Gemma Gatta Involved in the following research programmes:
Italian Cancer Registries; methodology of case-control studies for screening evaluation; evaluation of educational program on tobacco. EUROCARE: European cancer registries based study of cancer patients survival and care; editor of special issue on childhood cancer survival in Europe for the European Journal of Cancer ( EJC,200);IARC technical report ‘Evaluation of clinical care by cancer registry’ 2003, among the editors.
Project leader (PL) of European founded projects, including, the late outcomes of cancer treatment, colorectal cancer in Europe and the US, rare cancers. PL of the National funded project on prostate cancer patients, rare cancers and mesothelioma survivors.
Fondazione IRCCS, Istituto Nazionale dei Tumori.
Dr. Alejandro Mohar Betancourt Head of the Epidemiology Unit.
Activities: (i) Coordinate, develop and participate in clinical research projects, with the subsequent publication of results in national and international journals and presentation at conferences ; (ii) Advice on the design and analysis of other projects both the institution and in collaboration with other research centers. (iii) Directs Graduate Thesis, Master and Doctor of the UNAM. ; (iv) Participate actively in Continuing Medical Education programs targeting medical residents, general practitioners, specialists and researchers in the area of epidemiology and clinical research in cancer.
Instituto Nacional de Cancerología.